Publication | Closed Access
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life
85
Citations
22
References
2020
Year
Lenvatinib appears to have modest activity in ACC. Toxicities are common but manageable and QOL was found to deteriorate in some domains.
| Year | Citations | |
|---|---|---|
Page 1
Page 1